0000904454-23-000101.txt : 20230209 0000904454-23-000101.hdr.sgml : 20230209 20230209210751 ACCESSION NUMBER: 0000904454-23-000101 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230208 FILED AS OF DATE: 20230209 DATE AS OF CHANGE: 20230209 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dietz Thomas John CENTRAL INDEX KEY: 0001574218 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36066 FILM NUMBER: 23608277 MAIL ADDRESS: STREET 1: C/O TRANSCEPT PHARMACEUTICAL, INC. STREET 2: 1003 W. CUTTING BLVD, STE 110 CITY: PT. RICHMOND STATE: CA ZIP: 94804 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Paratek Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001178711 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330960223 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 75 PARK PLAZA STREET 2: 4TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: (617) 807-6600 MAIL ADDRESS: STREET 1: 75 PARK PLAZA STREET 2: 4TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 FORMER COMPANY: FORMER CONFORMED NAME: Transcept Pharmaceuticals Inc DATE OF NAME CHANGE: 20090130 FORMER COMPANY: FORMER CONFORMED NAME: NOVACEA INC DATE OF NAME CHANGE: 20020724 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2023-02-08 0 0001178711 Paratek Pharmaceuticals, Inc. PRTK 0001574218 Dietz Thomas John C/O PARATEK PHARMACEUTICALS, INC. 75 PARK PLAZA, 3RD FLOOR BOSTON MA 02116 1 0 0 0 Common Stock 2023-02-08 4 A 0 20000 0 A 70000 D Represents restricted stock units granted to the Reporting Person under the Paratek Pharmaceuticals, Inc. 2015 Equity Incentive Plan. Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock. The restricted stock units shall vest on the one-year anniversary of February 8, 2023, subject to the Reporting Person's continued service with the Issuer through the vesting date. /s/ William M. Haskell, Attorney-in-Fact for Thomas John Dietz 2023-02-09